Form 8-K - Current report:
SEC Accession No. 0000950170-22-018315
Filing Date
2022-09-12
Accepted
2022-09-12 07:07:59
Documents
12
Period of Report
2022-09-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20220906.htm   iXBRL 8-K 81949
  Complete submission text file 0000950170-22-018315.txt   208516

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220906.xsd EX-101.SCH 2468
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220906_lab.xml EX-101.LAB 17762
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220906_pre.xml EX-101.PRE 11056
6 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220906_htm.xml XML 4697
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 221237365
SIC: 2834 Pharmaceutical Preparations